STOP your RSD.
Neridronate infusions designated breakthrough therapy for CRPS, taking patients off other pain medications and allowing them to get back to their activities. With no side effects.
CRPS / RSD is an extremely painful and disabling condition which represent an immense struggle for hundreds of thousands of patients worldwide, living in countries where the Neridronate treatment has not been enrolled yet. International Patients are welcomed to Italy to Treat their CRPS effectively.
What is Neridronate?
Neridronate is an amino-bisphosphonate that has been officially approved as a treatment for osteogenesis imperfecta, Paget’s disease of bone and complex regional pain syndrome (CRPS) in Italy. Neridronate is administered either intravenously or intramuscularly;
Internationally, Neridronic acid is the first investigational medicine to receive Breakthrough Therapy Designation for the treatment of CRPS. It was discovered and developed by Abiogen Pharma SPA, Pisa, Italy, where it was patented and recognized by AIFA as the approved therapy for CRPS.
Stop waiting and take action now: the earlier chronic diseases are treated the better the outcome.
2019 AIFA approved Treatment
“In our opinion, drug therapy should be preferred as early as possible, particularly in warm forms of CRPS to prevent significant functional limitation, psychological distress, and social and economic fallout.”
International Osteopororis Foundation's research
More official and Scientific evidence of the approval of Neridronate for CRPS/RSD.
Italian Journal of Medicine
Neridronate confirmed at page 25 of the Italian Journal of Medicine with case study. Please feel free to download for free this issue of the Journal of Medicine where you can find official confirmation that the Neridronate therapy works, when administered accordingly to the patent.
Neridronate Trial Success
Several Academic publications showing results that you can verify.
Articles from publishers as Pulsus Group, the medical peer-review publisher, publishes the work of medical researchers in a manner that exemplifies the highest standards in research integrity. Endorsed by medical societies, Pulsus Group is an ardent supporter of international medical research, and publishes the following journals directed at a broad range of physician specialties
We are here for you!
Our Personal Health Planners are always available for a free of charge consultation; we will give you all the informations you might need, plus get in touch with our experienced team of CRPS specialists, who will evaluate your case and give us the feedback for you. All for free, as it should be.